Wilhelm Sander Foundation

from Wikipedia, the free encyclopedia
Wilhelm Sander Foundation
legal form legally responsible foundation
founding 1974
founder Wilhelm Sander
Seat Neustadt an der Donau
purpose Medical research
Chair Bernhard Knappe
sales 19,805,000 euros (2018)
Foundation capital 140,915,000 euros (2018)
Employees 30 (2018)
Website www.wilhelm-sander-stiftung.de

The Wilhelm Sander Foundation emerged from the estate of the manufacturer Wilhelm Sander, who died on December 31, 1973 in Neustadt an der Donau . The purpose of the foundation is to promote medical research, particularly the fight against disease and cancer. The focus of funding is increasingly cancer research .

For this purpose, the non-profit Wilhelm Sander Foundation has made around 245 million euros available since its establishment, primarily for projects in clinical and clinical-experimental cancer research, with which more than 2,260 research projects have been funded to date.

Life of the founder

Administration building Neustadt

Wilhelm Sander was born on August 26, 1897 as the son of a doctor in Roth near Nuremberg. In 1923 he founded the company Dr. Ruhland Nachf. A factory for medical sutures . After the company was destroyed in an air raid during the Second World War , Sander moved the company to Neustadt an der Donau, where he also took up residence.

Even before the currency reform , Wilhelm Sander had started to invest in rental residential buildings, initially by buying older buildings in Herne and Gießen, and later by building rental apartments. From the end of the 1950s, Wilhelm Sander started building large-scale apartments. He had housing estates built in Munich, Nuremberg and above all in the Leverkusen area. In the sixties, Wilhelm Sander turned his attention to the housing market in Switzerland and acquired several properties there. Most recently, he was the direct owner of 4,404 apartments in Germany and Switzerland and owned a further 227 apartments in Switzerland through investments in companies.

The image of the founder, who experienced the ups and downs of the 20th century, reveals a multifaceted personality: he was considered economical, sober calculating and in the eyes of some contemporaries even stingy. He also allowed unconventional methods when it came to increasing his property and showed neither charitable commitment nor social responsibility outside of his personal surroundings.

Wilhelm Sander probably also made the decision to use the foundation's income exclusively for medical research projects, in particular for combating disease and cancer, for personal reasons. In his immediate environment, he was confronted with the cancer of his long-time colleague and housekeeper Lina Burkhardt, who died of multiple myeloma - a type of bone marrow cancer. The painful loss of someone close to him and the fear of illness gave Wilhelm Sander the decisive impetus to set up this foundation.

organization

The statutes of the Wilhelm Sander Foundation sees in § 4 three internal bodies , namely the Board of Trustees, the Board and the Scientific Committee.

The foundation board is the highest body of the foundation. He is responsible for all tasks, unless they are assigned to other organs by law or the statutes (Section 4 (1) of the statutes). This includes, in particular, the appointment, supervision and dismissal of the board of directors, the representation of the foundation vis-à-vis the board of directors, the establishment of the annual financial plan as well as the financial statement and the decision on the use of the funds available for the purpose of the foundation according to the statutes.

The Board of Trustees consists of five members, two of whom are medical professionals, namely a permanent representative of the medical faculty of the Ludwig Maximilians University in Munich and, alternately after an appointment period of four years, a representative of the medical faculty of another Bavarian university. The three other members of the Board of Trustees are each appointed individually by the President of the Regensburg Chamber of Commerce , the President of the Regensburg Regional Court and the Bavarian State Minister for Science, Research and Art.

The board of directors is the foundation's executive body. He is responsible for the administration of the extensive foundation assets as well as the organization and processing of the funding application process.

The task of the Scientific Advisory Board is to advise and support the other foundation bodies in fulfilling their statutory duties. In particular, one member of the advisory board coordinates the review process of the individual grant applications submitted to the foundation and summarizes the result of the review in a template for the advisory board members and the foundation board, together with a proposal for a decision. The members of the advisory board then decide in an oral hearing or by circulation procedure on the individual applications, and the majority decision then serves the foundation board as a proposal for its final decision.

This procedure enables the Wilhelm Sander Foundation to guarantee the high quality of the approval process and the independence of individual interests for the applications submitted.

Board of Trustees

  • Harald Spiegel (Chairman), Prof. Dr. Thomas Kirchner (Deputy Chairman), Prof. Dr. Wolfgang Herr, Dr. Michael Mihatsch, Jochen Schenk, Dr. Jörg Koppenhöfer

Scientific Advisory Board Prof. Dr. Hermann Einsele (Chairman), Prof. Dr. Anja Katrin Bosserhoff, Prof. Dr. Thomas Gudermann, Prof. Dr. Thomas Hünig , Prof. Dr. Olaf Ortmann , Prof. Dr. Wilko Weichert, Prof. Dr. Jens Werner, Prof. Dr. Sabine Werner , Prof. Dr. Ralf Bartenschlager

Board

  • Bernhard Knappe (CEO), Munich
  • Ulrich Reuter, Leverkusen

The foundation is a member of the Federal Association of German Foundations and its committees consider the principles of good foundation practice to be binding.

Funding target

Research projects in the field of human medicine with a focus on cancer research (clinical and clinical-experimental) are supported. Research projects that do not deal with oncological issues must be directly related to the patient.

Funding is limited to Germany and Switzerland.

literature

  • Wilhelm Sander Foundation (Ed.): Sander Foundation. 1975 to 2005. Founder - development - activity . Gorbach GmbH, Utting 2005, ISBN 3-929691-06-X .
  • Wilhelm Sander Foundation (Ed.): Wilhelm Sander Foundation Report 2009–2011 . Gorbach GmbH, Utting 2012, ISBN 978-3-929691-18-4 .
  • Wilhelm Sander Foundation (Ed.): Wilhelm Sander Foundation Report 2006–2008 . Gorbach GmbH, Utting 2009, ISBN 978-3-929691-15-3 .
  • Wilhelm Sander Foundation (Ed.): Wilhelm Sander Foundation Report 2003–2005 . Gorbach GmbH, Utting 2006, ISBN 3-929691-07-8 .
  • Wilhelm Sander Foundation (Ed.): Wilhelm Sander Foundation Report 2000–2002 . Urban & Vogel, Munich 2003, ISBN 3-89935-198-3 .

Web links

Individual evidence

  1. ↑ Transparent civil society initiative. In: wilhelm-sander-stiftung.de. Retrieved March 18, 2020 .
  2. ↑ https://www.wilhelm-sander-stiftung.de/stiftung/wilhelm-sander/ https://www.wilhelm-sander-stiftung.de/stiftung/
  3. ↑ Principles of good foundation practice